The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Vieira, Frederico; Makoni, Marjorie; Szyld, Edgardo; Sekar, Krishnamurthy

Vieira, Frederico; Makoni, Marjorie; Szyld, Edgardo; Sekar, Krishnamurthy.

Affiliation

Vieira F; Neonatal Perinatal Section, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Makoni M; Neonatal Perinatal Section, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Szyld E; Neonatal Perinatal Section, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Sekar K; Neonatal Perinatal Section, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Front Pediatr ; 9: 631765, 2021.

Article de En | MEDLINE | ID: mdl-33869113

Mots clés

cardiovascular; inhaled nitric oxide; inhaled nitric oxide (iNO); persistent pulmonary hypertension of the newborn; pre-term infants; pulmonary hypertension

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials Langue: En Journal: Front Pediatr Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google